腫瘤壞死因子受體2重組兔單克隆抗體-抗體-抗體-生物在線
上海雅吉生物科技有限公司
腫瘤壞死因子受體2重組兔單克隆抗體

腫瘤壞死因子受體2重組兔單克隆抗體

商家詢價

產品名稱: 腫瘤壞死因子受體2重組兔單克隆抗體

英文名稱: TNFR2

產品編號: YJ-52950

產品價格: null

產品產地: 上海

品牌商標: 雅吉

更新時間: null

使用范圍: WB, IF, ICC

上海雅吉生物科技有限公司
  • 聯系人 :
  • 地址 : 上海市閔行區元江路5500號第1幢5658室
  • 郵編 :
  • 所在區域 : 上海
  • 電話 : 158****3937 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : yajikit@163.com

?
?中文名稱?腫瘤壞死因子受體2重組兔單克隆抗體?
別? ? 名 TNF Receptor II; CD120b; p75; p75TNFR; p80 TNF alpha receptor; p80 TNF-alpha receptor; TBP-2; TBPII; TNF R2; TNF R75; TNF-R2; TNF-RII; TNFR-II; TNFR80; TNFRII; TNFRSF1B; TNR1B_HUMAN; Tumor necrosis factor receptor 2; Tumor necrosis factor receptor type II; Tumor necrosis factor-binding protein 2.? ?
研究領域 腫瘤? 細胞生物? 神經生物學? 信號轉導? 細胞凋亡? 細胞膜受體? ?
抗體來源 Rabbit?
克隆類型 Monoclonal?
克 隆 號 7D3?
交叉反應 (predicted: Human, Mouse, Rat, )?
產品應用 WB=1:500-2000 IP=1:10-50 IHC-P=1:50-200 IHC-F=1:50-200 ICC=1:50-200 IF=1:50-200 (石蠟切片需做抗原修復)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.?
分 子 量 46kDa?
細胞定位 細胞膜 分泌型蛋白??
性? ? 狀 Liquid?
濃? ? 度 1mg/ml?
免 疫 原 KLH conjugated synthetic peptide derived from human TNFR2:??
亞? ? 型 IgG?
純化方法 affinity purified by Protein A?
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.?
保存條件 Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.?
PubMed PubMed?
產品介紹 The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein and TNF-receptor 1 form a heterocomplex that mediates the recruitment of two anti-apoptotic proteins, c-IAP1 and c-IAP2, which possess E3 ubiquitin ligase activity. The function of IAPs in TNF-receptor signalling is unknown, however, c-IAP1 is thought to potentiate TNF-induced apoptosis by the ubiquitination and degradation of TNF-receptor-associated factor 2, which mediates anti-apoptotic signals. Knockout studies in mice also suggest a role of this protein in protecting neurons from apoptosis by stimulating antioxidative pathways. [provided by RefSeq, Jul 2008]
?
Function:
Receptor with high affinity for TNFSF2/TNF-alpha and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. The TRAF1/TRAF2 complex recruits the apoptotic suppressors BIRC2 and BIRC3 to TNFRSF1B/TNFR2. This receptor mediates most of the metabolic effects of TNF-alpha. Isoform 2 blocks TNF-alpha-induced apoptosis, which suggests that?